Skip to main content

Table 4 Glucose profile between patients with 1hPG < 155vs  ≥ 155 mg/dL and with 2hPG < 140 mg/dLv ≥ 140 mg/dL

From: Oral glucose tolerance testing at 1 h and 2 h: relationship with glucose and cardiometabolic parameters and agreement for pre-diabetes diagnosis in patients with morbid obesity

Glucose 1 h (mg/dL) 1hPG 2hPG
n  < 155  ≥ 155 p-value n  < 140  ≥ 140 p-value
1hPG [mg/dL, mean (SD)] 656 143.4 (33.8) 184.2 (30.8)  < 0.001
2hPG [mg/dL, mean (SD)] 656 109.7 (21.4) 137.7 (26.9)  < 0.001
Fasting glucose [mg/dL, mean (SD)] 656 88.6 (9.5) 98.0 (10.0)  < 0.001 656 91.3 (10.3) 97.8 (10.8)  < 0.001
HbA1c [%, mean (SD)] 656 5.3 (0.4) 5.6 (0.4)  < 0.001 656 5.4 (0.4) 5.6 (0.4)  < 0.001
Peptide C [ng/mL, mean (SD)] 629 3.3 (1.1) 3.9 (1.3)  < 0.001 629 3.5 (1.2) 4.0 (1.3)  < 0.001
Homa-IR [median (IQR)] 654 3.3 (2.4) 4.3 (3.4)  < 0.001 654 3.4 (2.7) 4.6 (3.1)  < 0.001
HOMA-β [median (IQR)] 654 251.5 (216.0) 212.1 (205.0) 0.003 654 226.5 (204.3) 237.0 (222.3) 0.402
Insulinogenic index (median (IQR)) 643 1.66 (1.54) 1.02 (0.89)  < 0.001 643 1.42 (1.43) 1.02 (0.88)  < 0.001
  1. 1hPG 1-h plasma glucose concentration, 2hPG 2-h plasma glucose concentration, HbA1c glycated haemoglobin, HOMA-β homeostatic model assessment for cell-β function, HOMA-IR homeostatic model assessment for insulin resistance, IQR Interquartile range, PG post-load glucose, SD standard deviation